ClinicalTrials.gov record
Recruiting Phase 1 Interventional

SLV-154 Treatment of Metastatic Solid Tumors

ClinicalTrials.gov ID: NCT06771219

Public ClinicalTrials.gov record NCT06771219. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 10:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1 Dose-Escalation Study of SLV-154 in Subjects With Metastatic Solid Tumors

Study identification

NCT ID
NCT06771219
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Solve Therapeutics
Industry
Enrollment
70 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 13, 2025
Primary completion
Dec 31, 2026
Completion
Mar 31, 2027
Last update posted
Jan 22, 2026

2025 – 2027

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 Recruiting
Washington University St Louis Missouri 63110 Recruiting
Astera Cancer Care East Brunswick New Jersey 08816 Recruiting
Memorial Sloan Kettering Cancer Center New York New York 10065 Recruiting
MD Anderson Cancer Center Houston Texas 77030 Recruiting
Oncology Consultants Houston Texas 77030 Recruiting
Mays Cancer Center; University of Texas Health San Antonio San Antonio Texas 78229 Recruiting
University of Washington / Fred Hutchinson Cancer Center Seattle Washington 98109 Recruiting
Northwest Medical Specialties, PLLC Tacoma Washington 98405 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06771219, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 22, 2026 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06771219 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →